Mary Beard
Impact in
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Co-authors
- Susan McLaughlin (6 shared papers)André Rogatko (4 shared papers)R. Katherine Alpaugh (3 shared papers)Louis M. Weiner (5 shared papers)Steven J. Cohen (5 shared papers)Margaret von Mehren (2 shared papers)Neal J. Meropol (4 shared papers)Jeffrey Schlom (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Journal of Thoracic and Cardiovascular Surgery (1 paper)Annals of Surgical Oncology (1 paper)Sarcoma (1 paper)American Journal of Clinical Oncology (1 paper)
- Partner nations
- United States
In The Last Decade
Mary Beard
9 papers receiving 413 citations
Peers
Comparison fields: 5 of 50
- Oncology 208
- Immunology 113
- Cancer Research 35
- Biotechnology 22
- Pulmonary and Respiratory Medicine 60
Countries citing papers authored by Mary Beard
This map shows the geographic impact of Mary Beard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Beard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Beard more than expected).
Fields of papers citing papers by Mary Beard
This network shows the impact of papers produced by Mary Beard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Beard. The network helps show where Mary Beard may publish in the future.
Co-authors
The 25 scholars most cited alongside Mary Beard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma. | 2001 | 138 |
| 2 | 2003 | 135 | |
| 3 | Phase I and pharmacokinetic study of once daily oral administration of S-1 in patients with advanced cancer. | 2002 | 37 |
| 4 | 2004 | 29 | |
| 5 | 2006 | 29 | |
| 6 | 2003 | 20 | |
| 7 | 2008 | 12 | |
| 8 | 2009 | 10 | |
| 9 | 2007 | 9 |
About Mary Beard
Mary Beard is a scholar working on Surgery, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Immunology, having authored 9 papers that have together received 419 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (2 papers), Ubiquitin and proteasome pathways (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Renal cell carcinoma treatment (1 paper), Immunotherapy and Immune Responses (1 paper), vaccines and immunoinformatics approaches (1 paper), Peptidase Inhibition and Analysis (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Oncology (208 citations), Immunology (113 citations), Cancer Research (35 citations), Biotechnology (22 citations) and Pulmonary and Respiratory Medicine (60 citations). Mary Beard has collaborated with scholars based in United States. Frequent co-authors include Susan McLaughlin, André Rogatko, R. Katherine Alpaugh, Louis M. Weiner, Steven J. Cohen, Margaret von Mehren, Neal J. Meropol, Jeffrey Schlom, Philip M. Arlen and James L. Gulley. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic and Cardiovascular Surgery, Annals of Surgical Oncology, Sarcoma and American Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.